AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $626,493 | -64.6% | 8,964 | -63.6% | 0.00% | -66.7% |
| Q2 2023 | $1,767,682 | +136400.5% | 24,599 | +117038.1% | 0.00% | – |
| Q1 2023 | $1,295 | -99.7% | 21 | -99.8% | 0.00% | -100.0% |
| Q3 2021 | $411,000 | -59.1% | 12,506 | -16.2% | 0.00% | -50.0% |
| Q2 2021 | $1,006,000 | +159.3% | 14,921 | +117.0% | 0.00% | +100.0% |
| Q1 2021 | $388,000 | -22.4% | 6,876 | +11.8% | 0.00% | 0.0% |
| Q4 2020 | $500,000 | -14.2% | 6,150 | -25.0% | 0.00% | 0.0% |
| Q3 2020 | $583,000 | -69.4% | 8,199 | -64.7% | 0.00% | -75.0% |
| Q2 2020 | $1,904,000 | +1713.3% | 23,204 | +1197.0% | 0.00% | – |
| Q1 2020 | $105,000 | – | 1,789 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |